During the past decade, Nakamura Memorial Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nakamura Memorial Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Ministry of Health, Labour and Welfare, Japan" with 2 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Joseph Broderick, MD" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nakamura Memorial Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "China Medical University Hospital" with 1 trials as a collaborator, "Iwate Medical University" with 1 trials as a collaborator and "Japan Cardiovascular Research Foundation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Nakamura Memorial Hospital" are "Migraine" (3 trials), "Intracerebral Hemorrhage" (2 trials), "Subarachnoid Hemorrhage" (2 trials), "Acute Ischemic Stroke" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Nakamura Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Nakamura Memorial Hospital" are "Drug" (8 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bare platinum coil" (1 trials), "Bevacizumab" (1 trials), "DS1040b" (1 trials) and "Eicosapentaenoic acid ethyl ester" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nakamura Memorial Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Nakamura Memorial Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nakamura Memorial Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nakamura Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".